Results 131 to 140 of about 22,135 (184)

Polyomavirus Persistence

Annual Review of Virology, 2016
Mammalian polyomaviruses are characterized by establishing persistent infections in healthy hosts and generally causing clinical disease only in hosts whose immune systems are compromised. Despite the fact that these viruses were discovered decades ago, our knowledge of the mechanisms that govern viral persistence and reactivation is limited.
Mengxi Jiang, Michael Imperiale
exaly   +3 more sources

Polyomavirus BK

The Lancet Infectious Diseases, 2003
Polyomavirus hominis 1, better known as BK virus (BKV), infects up to 90% of the general population. However, significant clinical manifestations are rare and limited to individuals with impaired immune functions. BKV has been associated with diverse entities such as haemorrhagic cystitis, ureteric stenosis, vasculopathy, pneumonitis, encephalitis ...
Hirsch HH, Steiger J
openaire   +3 more sources

BK Polyomavirus Consensus

Clinical Infectious Diseases, 2022
To the editor—BK polyomavirus (BKPyV) continues to challenge kidney transplantation (KT) outcomes with premature renal allograft failure, and evidence-based treatment approaches based on randomized clinical trials are sorely lacking. Imlay and coauthors [1] address this unmet need and note that “definitions of proven disease are variable.” The ...
Hirsch, Hans   +2 more
openaire   +3 more sources

The biology of JC polyomavirus

Biological Chemistry, 2017
Abstract JC polyomavirus (JCPyV) is the causative agent of a fatal central nervous system demyelinating disease known as progressive multifocal leukoencephalopathy (PML). PML occurs in people with underlying immunodeficiency or in individuals being treated with potent immunomodulatory therapies.
Benedetta Assetta, Walter J. Atwood
openaire   +2 more sources

Home - About - Disclaimer - Privacy